Additions and corrections

A DFT study on the mechanism of a novel, regioselective, intramolecular N–π rearrangement of cis and trans-η¹-N-Cp*Rh-hydroxytamoxifen complexes to their η⁶ derivatives; potential breast cancer pharmaceuticals, and fluorescent probes

Irena Efremenko, Siden Top, Jan M. L. Martin and Richard H. Fish

Dalton Trans., 2009, 4334 (DOI: 10.1039/b819474b). Amendment published 30th March 2009.

In the first sentence of the last paragraph of the Conclusions the word cytotoxic is incorrect. The sentence should read as shown below.

Finally, this unique N–π rearrangement provided the cis-η⁶-Cp*Rh complex, 6, which was found to inhibit the growth of the MCF7 (ERα) breast cancer cell line, with an IC₅₀ of 1.25 μM.²¹

The Royal Society of Chemistry apologises for this error and any consequent inconvenience to authors and readers.

Back